Position in LLY
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$4,028,884
+$696,558 QoQ
Shares Held
3,359
-7.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.56%
of 13F equity value
Holder Rank
#1,880
of 4,605 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Texas Bank & Trust Co holds $17,417,326 across 10 Drug Manufacturers - General names. LLY ranks #2 (23.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
18,940 | $4,810,191 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
3,359 | $4,028,884 | |
| 3 | MRK |
Merck & Co., Inc.
|
14,116 | $1,813,904 | |
| 4 | AZN |
Astrazeneca PLC
|
9,355 | $1,773,894 | |
| 5 | ABBV |
AbbVie Inc.
|
5,258 | $1,323,121 | |
| 6 | NVS |
Novartis AG
|
5,429 | $850,832 | |
| 7 | GSK |
GSK plc
|
16,048 | $841,235 | |
| 8 | PFE |
Pfizer Inc
|
32,803 | $789,894 |
All Filings in LLY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,028,884 | 3,359 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $3,332,326 | 3,623 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $4,558,791 | 4,242 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $3,306,842 | 4,334 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $3,433,828 | 4,405 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $3,795,055 | 4,595 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,663,912 | 4,746 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||